Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.08T | 2.00T | 1.96T | 2.58T | 2.65T | Gross Profit |
150.31B | 147.45B | 135.16B | 170.39B | 176.98B | EBIT |
29.53B | 23.43B | 19.04B | 15.62B | 15.38B | EBITDA |
45.16B | 35.55B | 30.32B | 25.89B | 25.12B | Net Income Common Stockholders |
22.58B | 17.13B | 13.95B | 11.08B | 11.41B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
832.00M | 443.00M | 205.00M | 438.00M | 295.00M | Total Assets |
794.25B | 707.50B | 665.18B | 684.28B | 680.92B | Total Debt |
5.27B | 5.42B | 6.12B | 6.59B | 7.23B | Net Debt |
4.44B | 4.98B | 5.92B | 6.16B | 6.93B | Total Liabilities |
590.38B | 524.89B | 494.89B | 487.28B | 496.89B | Stockholders Equity |
203.84B | 182.59B | 170.16B | 196.88B | 183.92B |
Cash Flow | Free Cash Flow | |||
47.09B | 15.64B | 8.37B | 14.63B | -10.38B | Operating Cash Flow |
55.96B | 24.50B | 19.28B | 23.83B | 2.28B | Investing Cash Flow |
-7.73B | -11.24B | -11.83B | -6.26B | -10.96B | Financing Cash Flow |
-7.30B | -5.74B | -39.65B | -5.20B | -4.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $632.54B | 13.95 | 12.63% | 2.45% | 8.14% | 13.37% | |
73 Outperform | ¥232.92B | 10.55 | 3.46% | 2.47% | 2.88% | ||
73 Outperform | ¥3.64T | 126.56 | 2.60% | 0.88% | 6.08% | -35.70% | |
71 Outperform | ¥5.77T | 33.40 | 4.37% | 1.93% | 4.37% | -21.49% | |
71 Outperform | €384.75B | 20.29 | 10.66% | 1.19% | 17.14% | -14.26% | |
71 Outperform | ¥232.09B | 13.04 | 2.75% | 11.24% | -41.84% | ||
64 Neutral | $8.89B | 14.76 | 4.72% | 174.26% | 3.61% | 4.20% |